News
Local
Sports
Business
Entertainment
Lifestyle
Opinion
Real Estate News
Hot Property
eNewspaper
________________
Subscriptions
Manage Subscription
EZPay
Delivery Issue
eNewspaper
Subscribe
Subscriber Terms
Gift Subscription Terms
Manage Subscription
EZPay
Delivery Issue
eNewspaper
Subscribe
Subscriber Terms
Gift Subscription Terms
About Us
Contact us
Our Journalism Explained
Newsletters
Readers Rep
Careers
Events
Historical Archives
Podcasts and Livestreams
U-T Store
Contact us
Our Journalism Explained
Newsletters
Readers Rep
Careers
Events
Historical Archives
Podcasts and Livestreams
U-T Store
Events
Advertising
Place an ad
Media kit
Rate book
Report an ad problem
Cars
Classifieds
Eldercare Directory
Jobs
Newspaper ad directory
Newspaper special sections
Real Estate
Sponsored
Stats Digital
Place an ad
Media kit
Rate book
Report an ad problem
Cars
Classifieds
Eldercare Directory
Jobs
Newspaper ad directory
Newspaper special sections
Real Estate
Sponsored
Stats Digital
Jobs
CaregiverSD
Community papers
Del Mar Times
Encinitas Advocate
La Jolla Light
PB Monthly
Point Loma-OB Monthly
Pomerado News
Poway News Chieftain
Ramona Sentinel
Rancho Bernardo
Rancho Santa Fe Review
Del Mar Times
Encinitas Advocate
La Jolla Light
PB Monthly
Point Loma-OB Monthly
Pomerado News
Poway News Chieftain
Ramona Sentinel
Rancho Bernardo
Rancho Santa Fe Review
Games, Puzzles, and Crossword
Crossword
Sudoku
Crossword
Sudoku
Obituaries
Death Notices
Place an obituary
Death Notices
Place an obituary
U-T En Español
Deportes
Comunidad
Espectáculos
Cierre de Edición, fotos, videos
Noticias
Deportes
Comunidad
Espectáculos
Cierre de Edición, fotos, videos
Noticias
Privacy and Terms
Privacy
Terms
Advertising terms
Privacy
Terms
Advertising terms
Copyright © 2022, The San Diego Union-Tribune |
CA Notice of Collection
|
Do Not Sell My Personal Information
Sections
Sports
Business
Entertainment
Lifestyle
Opinion
Real Estate
Obituaries
eNewspaper
Newsletters
Show Search
Search Query
Submit Search
COVID-19
For subscribers
Phenomenal women
Latino life
Crossword
Sudoku
About Us
Contact us
Community Advisory Board
Readers Rep
Careers
Events
Historical Archives
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Local Stocks
San Diego Stocks
San Diego Stocks
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
2seventy bio, Inc. - Common Stock
(NQ:
TSVT
)
4.870
+0.050 (+1.04%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Aug 30, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about 2seventy bio, Inc. - Common Stock
< Previous
1
2
3
4
5
6
Next >
Week in Review: VectorBuilder Raises $57 Million for Gene Therapy Delivery CDMO
October 30, 2022
Via
Talk Markets
2seventy bio and JW Therapeutics Announce Strategic Partnership to Accelerate the Research and Development of T Cell-based Immunotherapies
October 27, 2022
From
2seventy bio, Inc.
Via
Business Wire
2seventy bio Announces Plans to Initiate KarMMa-9 Study of Abecma (idecabtagene vicleucel) in Newly Diagnosed Multiple Myeloma Patients
September 07, 2022
From
2seventy bio, Inc.
Via
Business Wire
2seventy bio to Participate in Upcoming Investor Conferences
August 31, 2022
From
2seventy bio, Inc.
Via
Business Wire
Recap Of Wednesday's Biotech Catalysts - End Of the Day Summary
August 10, 2022
Via
Benzinga
Biotech Daily: Cancer Causing Impurities In Merck's Diabetic Drug, Vir Bio-GSK Shun FDA Submission Plans For COVID-19 Treatment, Aethlon's Monkeypox Trial
August 10, 2022
Here's a roundup of top developments in the biotech space over the last 24 hours:
Via
Benzinga
2seventy Bio Shares Jump On Positive Data From Bristol Myers-Partnered Cancer Immunotherapy
August 10, 2022
Via
Benzinga
2seventy bio Reports Second Quarter Financial Results and Recent Operational Progress
August 10, 2022
From
2seventy bio, Inc.
Via
Business Wire
Bristol Myers Squibb and 2seventy bio Announce Topline Results from KarMMa-3 Trial Showing Abecma (idecabtagene vicleucel) Significantly Improves Progression-Free Survival Versus Standard Regimens in Relapsed and Refractory Multiple Myeloma
August 10, 2022
From
Bristol Myers Squibb
Via
Business Wire
2seventy bio to Participate in Upcoming Investor Conferences
August 03, 2022
From
2seventy bio, Inc.
Via
Business Wire
The Top E-Commerce Company to Buy for Summer 2022
June 17, 2022
There's definitely a chance that struggling RealReal simply goes bankrupt, but its network effects could make it a buyout target.
Via
InvestorPlace
The 5 Top Profit & Protection Stocks to Buy for 2022
June 17, 2022
It's important to know which quantitative factors make a stock worthwhile. These five have the attributes needed for success.
Via
InvestorPlace
2seventy bio to Participate in Goldman Sachs 43rd Annual Global Healthcare Conference
June 06, 2022
From
2seventy bio, Inc.
Via
Business Wire
2seventy bio Reports First Quarter Financial Results and Recent Operational Progress
May 12, 2022
From
2seventy bio, Inc.
Via
Business Wire
Benzinga's Top Ratings Upgrades, Downgrades For May 2, 2022
May 02, 2022
Upgrades
Via
Benzinga
Stocks That Hit 52-Week Lows On Tuesday
June 14, 2022
On Tuesday, 951 companies hit new 52-week lows.
Via
Benzinga
2seventy bio Presents New Preclinical Data on bbT369, an Investigational Dual-Targeting Gene-Edited CAR T Cell Therapy, at the AACR Annual Meeting
April 08, 2022
From
2seventy bio, Inc.
Via
Business Wire
2seventy bio to Participate in CG Horizons in Oncology Virtual Conference
April 07, 2022
From
2seventy bio, Inc.
Via
Business Wire
2seventy bio Reports Fourth Quarter and Full Year 2021 Financial Results and Recent Operational Progress
March 22, 2022
From
2seventy bio, Inc.
Via
Business Wire
2seventy bio Secures $170 Million in Private Placement Equity Financing
March 16, 2022
From
2seventy bio, Inc.
Via
Business Wire
Stocks That Hit 52-Week Lows On Friday
March 04, 2022
On Friday, 368 stocks hit new 52-week lows. Interesting Points From Today's 52-Week Lows: The largest company by market cap to set a new 52-week low was...
Via
Benzinga
Stocks That Hit 52-Week Lows On Tuesday
March 15, 2022
During Tuesday's session, 454 stocks hit new 52-week lows. Intriguing Points From Today's 52-Week Lows: Taiwan Semiconductor (NYSE:TSM) was the largest company by...
Via
Benzinga
Stocks That Hit 52-Week Lows On Tuesday
March 08, 2022
Tuesday's session saw 729 companies set new 52-week lows. Areas of Interest About Today's 52-Week Lows: Amazon.com (NASDAQ:AMZN) was the largest firm on a...
Via
Benzinga
2seventy bio Announces Key Management Appointments
February 14, 2022
From
2seventy bio, Inc.
Via
Business Wire
2seventy bio to Participate in Upcoming Healthcare Conferences
February 14, 2022
From
2seventy bio, Inc.
Via
Business Wire
Benzinga's Top Ratings Upgrades, Downgrades For February 10, 2022
February 10, 2022
Upgrades According to Gordon Haskett, the prior rating for Williams-Sonoma Inc (NYSE:WSM) was changed from Hold to Accumulate. Williams-Sonoma earned $3.32 in the third quarter,...
Via
Benzinga
12 Health Care Stocks Moving In Monday's After-Market Session
January 31, 2022
Gainers Oncternal Therapeutics (NASDAQ:ONCT
Via
Benzinga
12 Health Care Stocks Moving In Thursday's Pre-Market Session
January 13, 2022
Gainers iSpecimen (NASDAQ:ISPC) shares rose 19.8% to $8.18 during Thursday's pre-market session. The market value of their outstanding shares is at $71.4 million. VYNE...
Via
Benzinga
Bristol Myers, 2seventy Pull Plug On Multiple Myeloma CAR-T As Abecma Sales Gain Momentum
January 11, 2022
2seventy bio Inc's (NASDAQ: TSVT) anti-BCMA CAR-T got axed as part of a corporate update. The treatment was under development in collaboration with Bristol...
Via
Benzinga
2seventy bio Shares Key Milestones and Business Updates for 2022
January 11, 2022
From
2seventy bio, Inc.
Via
Business Wire
< Previous
1
2
3
4
5
6
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.